Sustiva

Known as: Bristol-Myers Squibb brand of efavirenz, Du Pont brand of efavirenz, United Drug brand of efavirenz 
 

Topic mentions per year

Topic mentions per year

1997-2015
0102019972015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
OBJECTIVE In developed countries, where the mother-to-child transmission rate of HIV is low (1 to 1,5%), a major medical concern… (More)
Is this relevant?
2002
2002
It was previously found that certain nonnucleoside reverse transcriptase inhibitors (NNRTI) possess virucidal activity against… (More)
  • figure 2
  • figure 1
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2001
2001
A series of 4,1-benzoxazepinone analogues of efavirenz (Sustiva) as potent NNRTIs has been discovered. The cis-3… (More)
Is this relevant?
2000
2000
Accumulating data have brought the nonnucleoside reverse transcriptase (RT) inhibitors (NNRTIs) into the forefront of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
1999
1999
Sustiva may cause false positives on urine tests that screen for marijuana use. A false positive, however, is unlikely to appear… (More)
Is this relevant?
1999
1999
  • Enid Vázquez
  • Positively aware : the monthly journal of the…
  • 1999
The PWA Health Group of New York City reports that some users of the anti-HIV drug Sustiva (efavirenz) who are recovering from… (More)
Is this relevant?
1999
1999
Efavirenz (Sustiva, Fig. 1) is a potent and specific inhibitor of HIV-1 reverse transcriptase approved for the treatment of HIV… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
1998
1998
DuPont Merck announced an expanded access program for Sustiva, a non-nucleoside transcriptase prohibitor. The once-daily drug in… (More)
Is this relevant?
1998
1998
  • Enid Vázquez
  • Positively aware : the monthly journal of the…
  • 1998
A non-nucleoside reverse transcriptase inhibitor, Sustiva (efavirenz, formerly DMP 266), received FDA approval for use by… (More)
Is this relevant?
1998
1998
  • Critical Path AIDS project
  • 1998
Dupont Pharma officials have confirmed that Sustiva (efavirenz) has been shown to cause false positives on THC tests. THC tests… (More)
Is this relevant?